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Background: Gastric cancer is the second leading cause of cancer-related deaths worldwide and it seems that environmental and lifestyle factors and infection with Helicobacter pylori (H. pylori) have a major role in the etiology of gastric cancer.
Objectives: The aim of this study was to investigate the presence of H. pylori DNA in archival gastric tissues of patients with gastric cancer disease by rapid, sensitive and specific technique of Scorpion real-time PCR.
Patients and Methods: This retrospective cross-sectional study was performed during the year 2009, on 285 paraffin embedded gastric specimens of patients, who were pathologically proved to have gastric cancer and were admitted to Bou-Ali, Shahid Rajaie and Dehkhoda Hospitals and Bahar and Farzam Private Laboratory of Qazvin city, Iran.
Results: The results of the Scorpion real-time PCR showed that H. pylori DNA was present in 8.42% of the total specimens. Modified McMullen’s staining of paraffin embedded sections were positive in ten patients. There was no significant relationship between the presence of H. pylori, sex, age and place of residence.
Conclusions: Although the existence of H. pylori in gastric tissue samples of patients with gastric cancer is controversial however, our results showed that in our studied specimens a significant number of patients with gastric cancer had H. pylori colonization.
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1. BackgroundGastric cancer is the second leading cause of cancer-related deaths worldwide. The International Agency for Research on Cancer reported that in Asia malignancy of the stomach is the most common cancer and nearly two-thirds of this disease occurs in developing coun-tries (1). Although the incidence and mortality of distal gastric cancers has decreased in the Western world, the incidence of proximal tumors is increasing in the male population of these regions. In contrast, in Asian coun-tries distal tumors have increased while proximal tumors have decreased (2). This geographic variation accompa-nied by differences in lifestyle, time trends and migrato-ry effects associated with the incidence of gastric cancer suggest that environmental and lifestyle factors have a major role in the etiology of gastric cancer (3, 4). Gastric cancer is an outcome of a complex interaction between host and environmental factors and Helicobacter pylori (H. pylori) infection. Scientific evidence suggests the impor-tance of host factors in gastric cancer pathogenesis (5). Helicobacter pylori are gram-negative, microaerophilic and spiral-shaped bacteria. Helicobacter pylori infection af-fects 50% of the population, worldwide (6). This infection 
initiates an inflammatory response, which is influenced by genetic polymorphisms, and in turn can either accen-tuate or attenuate the host's response to inflammation and affect the interaction of H. pylori, host and environ-mental factors. Helicobacter pylori infection is an estab-lished and important causal factor for non-cardia gastric adenocarcinoma. In the process of gastric carcinogene-sis, bacterial virulence factors that have been implicated include the cytotoxin-associated gene A antigen (Cag A), vacuolating cytotoxin (VacA), and outer membrane pro-teins (OMP) (7). The cagE genotype has been associated with gastric cancer in some studies, but contrary results have also been published (8, 9). Regardless of differences in researches opinion about the prevalence of H. pylori, an association between this infection and gastric cancer has been claimed by several reports in the literature (10-17).
2. ObjectivesWe planned this study to determine the overall preva-lence of H. pylori infection in patients with gastric carci-noma in our setup.
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3. Patients and MethodsThis retrospective cross-sectional study was performed on 345 paraffin embedded gastric specimens of patients who were pathologically proved to have gastric cancer and were admitted to Bou-Ali Shahid Rajaie and Dehkho-da Hospitals and Bahar and Farzam Private Laboratory of Qazvin city, Iran, during 2009.
3.1. Clinical SamplesInitially, the paraffin embedded gastric tissues were sectioned into 50 µm slices followed by DNA extraction using a DNA preparation protocol obtained from the Sec-tion of Cancer Genomics, Genetics Branch, NCI, Institute of Health Modified McMullen’s Staining of Gastric Biop-sy. The paraffin embedded sections were dewaxed, dehy-drated and covered by carbol fuchsin for two minutes. The sections were rinsed and stained with malachite green for two minutes. Then the slides were rinsed in tap water and air dried. With this procedure gull shaped H. pylori were stained in magenta against light green gas-tric tissue.
3.2. Scorpion Real-TimeScorpion real-time PCR was performed using the ABI Prism 7500 Sequence Detection System (Applied Bio-system, USA). The tails of the Scorpion primers were de-signed as previously described by Burucoa (18). All prim-ers and probes used were synthesized by the Metabion Company (Germany) (Table 1). The total volume of the re-al-time PCR was 20 µL containing 5 µL of DNA from a clini-cal sample or bacterial isolate, 0.1 µM of oligonucleotide primer 23SF2 and 0.08 µM of 23SScWT, and the rest of the volume consisted of distilled water. The cycling condi-tions were adjusted in a way suitable to be used by the ABI Prism 7500 Sequence Detection System (Applied Bio-system, USA) with an initial denaturation at 95°C for 45 seconds, 50 cycles at 95°C for 15 seconds, 55°C for 34 sec-onds, and 72°C for 20 seconds. Acquisition of a signal was achieved at 57°C during each cycle. A negative control for the Scorpion real-time PCR was obtained by observation of no amplification signal except internal amplification by adding DDW instead of DNA to the prepared real-time PCR master mix. The positive control for the Scorpion PCR was extracted DNA from H. pylori ATCC 26695. Positive ex-traction control was performed for each biopsy specimen in a separate tube in a final volume of 25 µL with Premix Ex Taq (TaKaRa, Shiga, Japan), 5 µL of extracted DNA from biopsy specimen, 0.25 µM of BGLO1 and BGLO2 primers, and 0.5 x Sybergreen 1 (Sigma Aldrich); on the basis of the results of this test, 285 of the collected biopsies were en-tered in our study. The cycling program consisted of one cycle at 95°C for 10 seconds and 40 cycles at 95°C for 5 seconds, 55°C for 34 seconds, and 72°C for 10 seconds. The Ethical Committee of Qazvin University of Medical Sci-ences approved our study. Data were analyzed using the SPSS 11.5 software with 95% confidence intervals (95% CI).
Table 1.  Scorpion Primers and Probe Sequences
Oligonucleotide Sequence
23SScWT 5’-FAM AAGGTAGGTGAAAATTCCTCCTAC-CBHQ1HEGGGACACGGGGTCTTT-3’
23SF2 5’-TGCGAACTGTGTGTTCACTAGC-3’
BGLO1 5’-ACACAACTGTGTGTTCACTAGC-3’
BGLO2 5’-CAACTTCATCCAACGTTCACC-3’
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Figure 1. Standard Curve Used to Calculate the Concentration of H. pylori DNA in Unknown samples
Figure 2. The PCR Product was Electrophoresed by Agarose Gel Electro-phoresis and Stained by Ethidium Bromide
Lane 1; H. pylori ATCC26695 was the positive control; lane 2, negative con-trol; lane 3, patients’ positive sample; lane 4, 100 bp DNA ladder.
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4. ResultsIn this survey the prevalence of H. pylori infection in gastric samples of patients with gastric cancer was de-termined using the data obtained from the following experiments:Detection of H. pylori by Scorpion real-time PCR: ini-tially, Scorpion real-time PCR was performed on H. pylori ATCC 26695. From the total of 285 samples, 24 biopsies were found to be positive for H. pylori by the Scorpion real-time PCR whereas 261 samples had negative results. Among samples with positive results for the Scorpion real-time PCR test, 10 samples also had positive results for the modified McMullen’s staining. Scorpion real-time PCR: Scorpion real-time PCR on DNA extracts of H. pylori ATCC 26695 as the control strain pro-duced the expected signals. The standard curve used to calculate the concentration of H. pylori DNA in unknown samples is presented in Figure 1A. The linear regression co-efficient was 0.996 and the efficiency of PCR was 92.054%. Figure 1B shows the fluorescent curves of the standard serial dilutions from 1 × 104 to 1 × 102 copies per microli-ter. Electrophoresis pattern of the Scorpion real-time PCR products on agarose gel is shown in Figure 2. A 140 base pair (bp) fragment in the peptidyl transferase gene of 23S rRNA showed successful amplification. Amongst all pa-tients (285 cases) with gastric cancer entered in the study, 24 cases (8.24%) were found to have H. pylori DNA in their gastric biopsy specimens by the Scorpion real-time PCR method. Our study showed that there is no significant association between sex, age, marital status, history of gastric involvement, gastric disease, and the presence of bacterium. Also no relationship was established between sex, family income, and accommodation variables and the colonization of H. pylori in gastric cancer tissues (data not shown).
5. DiscussionHelicobacter pylori infect humans during childhood and until now it has infected one half of the world’s popula-tion. It is the only bacterium, which is listed amongst microbial agents involved in human cancer diseases. Our findings showed that from the total of 285 formalde-hyde fixed paraffin embedded samples of pathologically proved gastric cancer patients entered in our study, 24 patients (8.42) had H. pylori DNA. The results of published researches in the medical literature related to the involve-ment of H. pylori in gastric cancer are controversial and confirmation of this involvement and determination of the level of this involvement in different societies are important issues. As H. pylori is a fastidious bacteria, mi-crobiological methods of culture and identification of these bacteria are difficult and require a long duration of time, thus adequate sensitivity and specificity of modern molecular methods in diagnosis of these bacteria make them attractive methods for studying the prevalence of H. pylori in different clinical specimens (19). Khanna et al. 
in a study on 50 proved cases of gastric cancer found that the prevalence rate of H. pylori infection in their patients was lower than in the control population, suggesting that H. pylori may not be responsible for gastric carcinogenesis in this population (16). In another study by Rudi and col-leagues on the sera of 111 Caucasian patients with histolog-ically confirmed gastric cancer, their data did not provide evidence that the contribution of H. pylori infection to the carcinogenesis of gastric cancer is of major significance, at least in a population with low gastric cancer rates and high socioeconomic status (17). On the other hand, Babus and colleagues analyzed 12 prospective case-control stud-ies and concluded that between 65% and 80% of non-cardia gastric cancers were attributable to H. pylori infection (12, 13). Uemura et al. studied 1526 Japanese patients, of whom 1246 had H. pylori infection and 280 were not infected. Over a mean follow-up period of 7.8 years, gastric cancer developed in 2.9% of patients with H. pylori infection while none of the uninfected patients developed gastric cancer, resulting in a relative risk of 34.5 (14). Martinez and col-leagues in a case-control study including 46 gastric can-cer cases and 99 controls with non-atrophic gastritis from a high-risk zone for gastric cancer showed that there is a positive association between Helicobacter pylori CagA posi-tive strains with non-cardia gastric cancer etiology (15). Al-though we studied a relatively large population and used the sensitive and specific method of Scorpion real time PCR, our results are in consistent with the latter studies indicating a possible role for H. pylori in gastric cancer.
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